Rachel J. Perry

10.0k total citations · 4 hit papers
110 papers, 6.8k citations indexed

About

Rachel J. Perry is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Rachel J. Perry has authored 110 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 44 papers in Physiology and 30 papers in Epidemiology. Recurrent topics in Rachel J. Perry's work include Adipose Tissue and Metabolism (35 papers), Metabolism, Diabetes, and Cancer (20 papers) and Pancreatic function and diabetes (19 papers). Rachel J. Perry is often cited by papers focused on Adipose Tissue and Metabolism (35 papers), Metabolism, Diabetes, and Cancer (20 papers) and Pancreatic function and diabetes (19 papers). Rachel J. Perry collaborates with scholars based in United States, Denmark and United Kingdom. Rachel J. Perry's co-authors include Gerald I. Shulman, Kitt Falk Petersen, Dongyan Zhang, Gary W. Cline, Varman T. Samuel, Liang Peng, João Paulo Camporez, Richard G. Kibbey, Rebecca Cardone and Natasha A. Barry and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Rachel J. Perry

102 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome

2016 989 citations Rachel J. Perry, Liang Peng et al. profile →
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

2014 895 citations Rachel J. Perry, Varman T. Samuel et al. profile →
Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes

2015 536 citations Rachel J. Perry, Dongyan Zhang et al. Cell profile →
Regulation of adipose tissue inflammation by interleukin 6

2020 246 citations Rachel J. Perry, Gerald I. Shulman et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel J. Perry United States	39	3.3k	2.6k	2.1k	1.5k	1.1k	110	6.8k
João Paulo Camporez United States	37	4.1k 1.2×	2.8k 1.1×	2.7k 1.3×	1.6k 1.0×	1.3k 1.1×	70	7.9k
Takeshi Imamura Japan	35	4.2k 1.3×	2.8k 1.1×	1.6k 0.7×	1.1k 0.7×	1.3k 1.1×	85	7.7k
Bruno Fève France	44	2.3k 0.7×	2.5k 1.0×	1.9k 0.9×	1.3k 0.8×	796 0.7×	178	7.4k
W. Timothy Garvey United States	38	2.7k 0.8×	2.6k 1.0×	1.6k 0.8×	1.5k 1.0×	1.0k 0.9×	98	6.5k
Hui‐Young Lee South Korea	37	3.1k 1.0×	2.1k 0.8×	1.4k 0.7×	1.1k 0.7×	1.1k 1.0×	122	6.3k
Bruno Guigas Netherlands	42	5.1k 1.6×	2.1k 0.8×	1.5k 0.7×	2.0k 1.3×	2.2k 1.9×	117	9.0k
Karen Inouye United States	24	2.5k 0.8×	2.2k 0.8×	2.3k 1.1×	744 0.5×	697 0.6×	39	6.2k
Robert M. O’Doherty United States	45	3.1k 0.9×	2.9k 1.1×	1.9k 0.9×	905 0.6×	1.4k 1.2×	83	6.9k
Rinke Stienstra Netherlands	45	3.5k 1.1×	2.0k 0.8×	3.5k 1.7×	1.0k 0.7×	921 0.8×	121	8.4k
Hang Shi United States	44	3.2k 1.0×	3.6k 1.4×	3.1k 1.5×	863 0.6×	908 0.8×	103	9.4k

Countries citing papers authored by Rachel J. Perry

Since Specialization

Citations

This map shows the geographic impact of Rachel J. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel J. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel J. Perry more than expected).

Fields of papers citing papers by Rachel J. Perry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel J. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel J. Perry. The network helps show where Rachel J. Perry may publish in the future.

Co-authorship network of co-authors of Rachel J. Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel J. Perry. A scholar is included among the top collaborators of Rachel J. Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel J. Perry. Rachel J. Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Seohyuk, Mariya Rozenblit, Kim Blenman, et al.. (2025). Accelerated Aging in Cancer and Cancer Treatment: Current Status of Biomarkers. Cancer Medicine. 14(9). e70929–e70929. 2 indexed citations

Li, Zongyu, David G. Gonzalez, Catherine Matte-Martone, et al.. (2025). Metabolic rewiring in skin epidermis drives tolerance to oncogenic mutations. Nature Cell Biology. 27(2). 218–231. 1 indexed citations

Zhang, Xinyi, Donald A. Morgan, Siresha Bathina, et al.. (2024). A kidney-hypothalamus axis promotes compensatory glucose production in response to glycosuria. eLife. 12.

Leitner, Brooks P., Won Dong Lee, Wanling Zhu, et al.. (2023). Tissue-specific reprogramming of glutamine metabolism maintains tolerance to sepsis. PLoS ONE. 18(7). e0286525–e0286525. 10 indexed citations

Zhang, Xinyi, Brooks P. Leitner, Wanling Zhu, et al.. (2023). Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma. American Journal of Physiology-Endocrinology and Metabolism. 325(4). E363–E375. 9 indexed citations

Akingbesote, Ngozi D., Brooks P. Leitner, Reina Desrouleaux, et al.. (2023). Gene and protein expression and metabolic flux analysis reveals metabolic scaling in liver ex vivo and in vivo. eLife. 12. 3 indexed citations

Akingbesote, Ngozi D., Brenda Cartmel, Leah M. Ferrucci, et al.. (2023). A review of the impact of energy balance on triple-negative breast cancer. JNCI Monographs. 2023(61). 104–124. 1 indexed citations

Leitner, Brooks P., et al.. (2022). Multimodal analysis suggests differential immuno-metabolic crosstalk in lung squamous cell carcinoma and adenocarcinoma. npj Precision Oncology. 6(1). 8–8. 12 indexed citations

Torres, Maria Corina Plaz, Ariel Jaffe, Rachel J. Perry, et al.. (2022). Diabetes medications and risk of HCC. Hepatology. 76(6). 1880–1897. 59 indexed citations

10.

Rasmussen, Bodil, Rachel J. Perry, Martha Hickey, et al.. (2022). Patient preferences using telehealth during the COVID‐19 pandemic in four Victorian tertiary hospital services. Internal Medicine Journal. 52(5). 763–769. 23 indexed citations

11.

Akingbesote, Ngozi D., Aaron D. Norman, Wanling Zhu, et al.. (2022). A precision medicine approach to metabolic therapy for breast cancer in mice. Communications Biology. 5(1). 478–478. 15 indexed citations

12.

Schumann, Tina, Jörg König, Christian von Loeffelholz, et al.. (2021). Deletion of the diabetes candidate gene Slc16a13 in mice attenuates diet-induced ectopic lipid accumulation and insulin resistance. Communications Biology. 4(1). 826–826. 14 indexed citations

13.

Arnold, Ben, et al.. (2021). PTU-30 Inadvertent wire cannulation of the pancreatic duct at ERCP: a retrospective analysis of outcomes. A57.1–A57. 1 indexed citations

14.

Nozaki, Yuichi, Max C. Petersen, Dongyan Zhang, et al.. (2020). Metabolic control analysis of hepatic glycogen synthesis in vivo. Proceedings of the National Academy of Sciences. 117(14). 8166–8176. 64 indexed citations

15.

Perry, Rachel J. & Gerald I. Shulman. (2020). Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks. Journal of Biological Chemistry. 295(42). 14379–14390. 74 indexed citations

16.

He, Feng, Yanrui Huang, Zhi Song, et al.. (2020). Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance. The Journal of Experimental Medicine. 218(3). 108 indexed citations

17.

Perry, Rachel J., Jon M. Resch, Amelia M Douglass, et al.. (2019). Leptin’s hunger-suppressing effects are mediated by the hypothalamic–pituitary–adrenocortical axis in rodents. Proceedings of the National Academy of Sciences. 116(27). 13670–13679. 65 indexed citations

18.

Perry, Rachel J., Yongliang Wang, Gary W. Cline, et al.. (2018). Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation. Cell. 172(1-2). 234–248.e17. 126 indexed citations

19.

Perry, Rachel J., Liang Peng, Gary W. Cline, et al.. (2017). Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA). Nature Communications. 8(1). 798–798. 46 indexed citations

20.

Lindsay, John F. & Rachel J. Perry. (1971). Preliminary evaluation of the coring potential of the Apollo lunar surface drill titanium core stem. NASA Technical Reports Server (NASA). 13(10). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact